Clinical Trials Directory

Trials / Completed

CompletedNCT03174860

Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success

Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success in Mandibular Molars With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the effect of preoperative Diclofenac Potassium (50 mg Cataflam) on the anesthetic success of buccal infiltration with 4% articaine with epinephrine 1:200,000 in mandibular molars with symptomatic irreversible pulpitis.

Detailed description

This study aims to evaluate the effectiveness of preoperative administration of Diclofenac Potassium (50 mg Cataflam) compared to placebo, one hour before treatment, on the anesthetic success of buccal infiltration with 4% articaine with epinephrine 1:200,000 in mandibular molars with symptomatic irreversible pulpitis. Patients with moderate-to-severe pre-operative pain are selected. Full medical and dental history will be obtained from all patients treated during this study by the operator. Clinical diagnosis of symptomatic irreversible pulpitis is to be confirmed. The primary outcome is success of buccal infiltration using articaine.The secondary outcomes are pain on injection. Patients will be recruited from the outpatient clinic of Endodontics at the Faculty of Oral and Dental Medicine, Cairo University.

Conditions

Interventions

TypeNameDescription
DRUGDiclofenac Potassium 50mg TabA 50 mg tablet of the medication to be taken one hour before initiation of endodontic treatment.
DRUGPlaceboA placebo will be taken one hour before initiation of endodontic treatment.

Timeline

Start date
2016-10-01
Primary completion
2018-02-01
Completion
2018-04-01
First posted
2017-06-05
Last updated
2018-07-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03174860. Inclusion in this directory is not an endorsement.